Lazard Asset Management’s Health Catalyst HCAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Sell |
81,537
-5,989
| -7% | -$22.6K | ﹤0.01% | 1616 |
|
|
2025
Q1 | $396K | Sell |
87,526
-10,030
| -10% | -$45.4K | ﹤0.01% | 1471 |
|
|
2024
Q4 | $689K | Sell |
97,556
-113,721
| -54% | -$803K | ﹤0.01% | 1272 |
|
|
2024
Q3 | $1.72M | Sell |
211,277
-29,903
| -12% | -$243K | ﹤0.01% | 904 |
|
|
2024
Q2 | $1.54M | Sell |
241,180
-27,857
| -10% | -$178K | ﹤0.01% | 889 |
|
|
2024
Q1 | $2.03M | Sell |
269,037
-24,148
| -8% | -$182K | ﹤0.01% | 826 |
|
|
2023
Q4 | $2.71M | Sell |
293,185
-12,001
| -4% | -$111K | ﹤0.01% | 797 |
|
|
2023
Q3 | $3.09M | Sell |
305,186
-9,124
| -3% | -$92.3K | ﹤0.01% | 800 |
|
|
2023
Q2 | $3.93M | Sell |
314,310
-18,757
| -6% | -$234K | ﹤0.01% | 756 |
|
|
2023
Q1 | $3.89M | Buy |
333,067
+11,185
| +3% | +$130K | 0.01% | 779 |
|
|
2022
Q4 | $3.42M | Sell |
321,882
-256,719
| -44% | -$2.73M | ﹤0.01% | 798 |
|
|
2022
Q3 | $5.61M | Buy |
578,601
+89,046
| +18% | +$864K | 0.01% | 684 |
|
|
2022
Q2 | $7.09M | Buy |
489,555
+117,099
| +31% | +$1.7M | 0.01% | 662 |
|
|
2022
Q1 | $9.73M | Buy |
372,456
+52,057
| +16% | +$1.36M | 0.01% | 625 |
|
|
2021
Q4 | $12.7M | Buy |
320,399
+242,478
| +311% | +$9.61M | 0.01% | 577 |
|
|
2021
Q3 | $3.9M | Buy |
77,921
+3,659
| +5% | +$183K | ﹤0.01% | 807 |
|
|
2021
Q2 | $4.12M | Buy |
74,262
+49,276
| +197% | +$2.74M | ﹤0.01% | 750 |
|
|
2021
Q1 | $1.17M | Buy |
24,986
+6,224
| +33% | +$291K | ﹤0.01% | 880 |
|
|
2020
Q4 | $816K | Buy |
+18,762
| New | +$816K | ﹤0.01% | 918 |
|